SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-057093
Filing Date
2020-05-06
Accepted
2020-05-05 21:02:34
Documents
17
Period of Report
2020-05-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018740-1_8k.htm   iXBRL 8-K 44527
2 EXHIBIT 99.1 tm2018740d1_ex99-1.htm EX-99.1 18614
3 EXHIBIT 99.2 tm2018740d1_ex99-2.htm EX-99.2 51649
8 GRAPHIC tm2018740d1_ex99-1img001.jpg GRAPHIC 6757
9 GRAPHIC tm2018740d1_ex99-1img002.jpg GRAPHIC 6757
  Complete submission text file 0001104659-20-057093.txt   402630

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA abbv-20200505.xsd EX-101.SCH 4481
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20200505_def.xml EX-101.DEF 30228
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20200505_lab.xml EX-101.LAB 41943
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20200505_pre.xml EX-101.PRE 28431
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2018740-1_8k_htm.xml XML 9939
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 20850883
SIC: 2834 Pharmaceutical Preparations